Table 2 Demographic characteristics of patients (n = 200) in the study
Variable | All patients | SA carriers | MRSA carriers |
|---|---|---|---|
| Â | (200 subjects) | (59 subjects) | (27 subjects) |
Age | Â | Â | Â |
 18-29 | 54 (27%) | 16 (27%) | 7 (26%) |
 30-39 | 43 (21.5%) | 15 (25.5%) | 4 (15%) |
 40-49 | 55 (27.5%) | 13 (22%) | 9 (33%) |
 50-59 | 39 (19.5%) | 13 (22%) | 7 (26%) |
 60 and up | 9 (4.5%) | 2 (3.5) | 0 (0%) |
Sex | Â | Â | Â |
 Male | 108 (54%) | 26 (44%) | 15 (55%) |
 Female | 92 (46%) | 33 (56%) | 12 (45%) |
Race | Â | Â | Â |
 White/Hispanic | 38 (19%) | 14 (24%) | 4 (15%) |
 Black | 159 (79.5%) | 45 (76%) | 23 (85%) |
 Asian, Pacific Islander | 2 (1%) | 0 | 0 |
 American Indian Alaskan Native | 0 | 0 | 0 |
 Other | 1 (0.5%) | 0 | 0 |
Hispanic/Spanish origin | Â | Â | Â |
 Yes | 3 (1.5%) | 1 (2%) | 0 |
 No | 195 (97.5%) | 58 (98%) | 27 (100%) |
 Unknown | 2 (1%) | 0 | 0 |
Primary complaint | Â | Â | Â |
 Respiratory | 26 (13%) | 6 (10.5%) | 3 (11%) |
 GI | 22 (11%) | 7 (12%) | 3 (11%) |
 Dermatology | 5 (2.5%) | 2 (3%) | 1 (4%) |
 Localized pain/weakness | 87 (43.5%) | 20 (35.5%) | 11 (41%) |
 UGI | 7 (3.5%) | 3 (4.5%) | 1 (4%) |
 Injury | 14 (7%) | 4 (6%) | 2 (7.5%) |
 Cardiovascular | 19 (9.5%) | 8 (13.5%) | 3 (11%) |
 Other | 18 (9%) | 9 (15%) | 3 (11%) |
 General pain/weakness | 2 (1%) | 0 | 0 |
Antibiotic prescribed | Â | Â | Â |
 Yes | 39 (19%) | 8 (14%) | 5 (18.5%) |
 No | 161 (79.5%) | 49 (86%) | 22 (71.5%) |
Admission to hospital | Â | Â | Â |
 Yes | 29 (14.5%) | 13 (22%) | 7 (26%) |
 No | 171 (75.5%) | 46 (78%) | 20 (74%) |